Retail sector stocks have been strong performers lately, with sector stocks in the S&P 500 handily outperforming the broader index in both the year-to-date and trailing 52-weeks as well as in response to the results that have come out already. In fact ... · 5/10/2015
My favourite of this lot is Pfizer as a growth stock. It has a manageable debt ... research dedicated to the pharmacological treatment of drug addiction and pharmaceutical companies are moving to develop and market medications for this growth area of ...
Trefis · 11/15/2012
(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter, U.S. stocks were little changed on Tuesday and trading was ...
Yahoo Finance UK and Ireland · 10/15/2013
More from Bing News
By now, demystifying insider moves is second nature to Moreland, who has been studying the link between insider activity and future stock performance since the early 1990s. Research by Moreland and others has shown that when top corporate...
Barron's · ByGrace L. Williams · 4/2/2014
It issued 10 million shares of its common stock at an offering price of $4.00 per share ... In the next part of the series, we’ll discuss Point72 Asset Management’s position in Catalyst Pharmaceutical Partners.
Market Realist · 1/16/2015
While there can be a lot of variability among biotech and medtech stocks, and other factors may have driven price performance outside of the shelf registration filing, the majority of stocks have had significant short-term price declines. Biotech and ...
Virtual-Strategy Magazine · 12/5/2014